Active, Not Recruiting
A Global Study of Midostaurin in Combination With Chemotherapy to Evaluate Safety, Efficacy and Pharmacokinetics in Newly Diagnosed Pediatric Patients With FLT3 Mutated AML
NCT03591510
- Conditions
- FLT3-mutated Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
- Locations
-
- Novartis Investigative Site Prague, Czechia
- Novartis Investigative Site Berlin, Germany
- Novartis Investigative Site Essen, Germany
- Novartis Investigative Site Pavia, PV, Italy